Archean Chemical Industries profit and loss

Latest FY26
Revenue
₹1,081cr+3.8% on FY25
EBITDA
₹239cr−24.0% on FY25
Net profit
₹105cr−35.0% on FY25
EPS
₹8.66−34.0% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,1801,0811,0411,3301,441
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
22.226.937.343.343.3
1,2021,1081,0781,3731,484
Expenses
12487.762.947.645.7
0.016.50.00.04.4
−32.1−39.9−70.740.1−47.4
77.374.261.172.472.0
25.225.78.18.597.0
93.592.979.470.368.6
776704674707732
1,063961814946973
236239314463634
142146235392565
Profit
139147264427512
0.00.0−40.20.00.0
139147224427512
55.354.165.410123.6
−14.1−12.4−3.87.6105
41.241.761.6108129
97.9105162319383
97.9105162319383
−0.3−0.2−0.2−0.30.3
97.6105162319383
——162319383
——−0.0−0.00.0
Per share
₹8.13₹8.66₹13.13₹25.90₹34.66
₹8.12₹8.65₹13.12₹25.87₹34.59
Other comprehensive income — detail
−0.3−0.2−0.2——
−0.4−0.3−0.2−0.40.4
−0.1−0.1−0.1——
———−0.10.1
——162319383
——−0.0−0.00.0
Per share — as-filed variants
₹8.13₹8.66₹13.13₹25.90₹34.66
₹8.12₹8.65₹13.12₹25.87₹34.59
Derived — gross profit (revenue − materials − purchases − Δ inventories)
1,0891,0171,0491,2421,438
92.2%94.1%100.7%93.4%99.8%
Adjusted (ex-exceptional items) — derived
139147264427512
0.00.0−40.20.00.0
97.9105191319383
₹8.13₹8.66₹15.49₹25.90₹34.66
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ACI₹454.40

Archean Chemical Industries Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersNEOGENAETHERALKYLAMINEBALAMINESTECILCHEMELLENGHCLGNFCMcap ₹5,610 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue from Operations1,441.11,330.11,041.01,081.11,180.1
Other Income43.343.337.326.922.2
Total Income1,484.31,373.41,078.31,108.01,202.3
Expenses
+ Cost of Materials Consumed45.747.662.987.7123.6
+ Purchases of Stock-in-Trade4.40.00.016.50.0
+ Changes in Inventories-47.440.1-70.7-39.9-32.1
+ Employee Benefit Expense72.072.461.174.277.3
+ Finance Costs97.08.58.125.725.2
+ Depreciation & Amortisation68.670.379.492.993.5
+ Other Expenses732.3707.3673.6703.8775.7
Total Expenses972.7946.2814.4960.91,063.1
EBITDA634.0462.7314.2238.8235.6
EBIT565.4392.3234.8145.9142.1
Profit
PBT before Exceptional Items511.7427.2263.9147.1139.1
+ Exceptional Items0.00.0-40.20.00.0
Pretax Income511.7427.2223.8147.1139.1
+ Current Tax23.6100.665.454.155.3
+ Deferred Tax105.57.6-3.8-12.4-14.1
Tax Expense129.1108.261.641.741.2
Net Income382.6319.0162.1105.497.9
+ Net Income — Continuing Ops382.6319.0162.1105.497.9
+ Other Comprehensive Income0.3-0.3-0.2-0.2-0.3
Total Comprehensive Income382.8318.7162.0105.297.6
Net Income to Common382.6319.0162.1——
Minority Interest0.0-0.0-0.0——
Per Share
Basic EPS34.6625.9013.138.668.13
Diluted EPS34.5925.8713.128.658.12
Other Comprehensive Income — detail
+ Other Comprehensive Income——-0.2-0.2-0.3
+ Items NOT to be Reclassified to P&L0.4-0.4-0.2-0.3-0.4
+ Tax on Items NOT to be Reclassified——-0.1-0.1-0.1
+ Tax on Items NOT to be Reclassified — alt tag0.1-0.1———
Comprehensive Income — Owners of Parent382.8318.7162.0——
Comprehensive Income — Non-controlling Interests0.0-0.0-0.0——
Per Share — as-filed variants
Basic EPS — Continuing Operations34.6625.9013.138.668.13
Diluted EPS — Continuing Operations34.5925.8713.128.658.12
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,438.31,242.41,048.81,016.81,088.6
Gross Margin %99.8193.41100.7594.0692.25
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)511.7427.2263.9147.1139.1
− Exceptional Items (reconciliation)0.00.0-40.20.00.0
Net Income Adj (tax-effected)382.6319.0191.3105.497.9
EPS Adj34.6625.9015.498.668.13
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.00
Paid Up Equity Capital24.624.724.724.724.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.